Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part A

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03116932

Enrollment

225

Registered

2017-04-17

Start date

2016-11-30

Completion date

2019-11-30

Last updated

2018-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Keywords

HIV prevention, high risk MSM, PrEP

Brief summary

The target population for this project will be men-who-have-sex-with-men (MSM) at high risk of HIV acquisition

Detailed description

225 high risk MSM will be interviewed to understand the knowledge and acceptability of pre-exposure prophylaxis (PrEP) in this population in Puerto Rico. A 187 item questionnaire will administered which will evaluate socio-demographic information, sexual conducts, PrEP knowledge and PrEP acceptability.

Interventions

BEHAVIORALPrEP knowledge and acceptability questionnaire

This questionnaire consists of 187 items and evaluates socio-demographic variables, sex conducts, PrEP knowledge and PrEP acceptability.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

21 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

; Study subjects who meet the following inclusion criteria will be considered for enrollment for Part A: 1. age 21 years or older 2. understand and sign the informed consent form and willing to participate in the study 3. male or transgender female 4. has one of the following risk factors: * a high risk MSM as defined by: * having unprotected sexual intercourse with at least two male partners in the past 6 months, or * diagnosed with an STI in the past 6 months. PART A -

Exclusion criteria

Subjects with any of the following will not be considered for enrollment in Part A: 1. Age younger than 21 years old 2. Unable or unwilling to provide an informed consent 3. Female gender at birth 4. Do not meet the high risk criteria

Design outcomes

Primary

Measure	Time frame	Description
PrEP acceptability using a PrEP knowledge and acceptability questionnaire.	One visit	Measure the degree of acceptance of PrEP in the study subjects
PrEP knowledge using a PrEP knowledge and acceptability questionnaire.	One visit	Measure the level of education of the study subjects in the topic of PrEP using a questionnaire.

Countries

Puerto Rico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026